Vaccine Evaluation Center, BC Children's Hospital Research Institute, University of British Columbia, 950 W 28th Ave rm a5-174, Vancouver, (British Columbia) V5Z 4H4, CanadaJulie A. BettingerVaccine Evaluation Center, BC Children's Hospital Research Institute, University of British Columbia, 950 ...
Conclusions This study illustrates the prevalence of hrHPV in BC over time in women undergoing cervical cancer screening, where an indication of a decline in HPV16/18 is seen in vaccine eligible women. 展开 关键词: Canada Cervical cancer screening HPV prevalence HPV vaccine evaluation Human ...
In Canada both bivalent (bHPV) vaccine and quadrivalent HPV vaccine (qHPV) are authorized for use. In Alberta, while both vaccines are available for private purchase, only qHPV is publicly funded for school girls in grades 5 and 9 as of 2013. We describe HPV vaccine uptake in Alberta, by...
prophylactic vaccination is an important and validated method of HPV prevention. There are currently three commercially available vaccines in Canada, two of which are recommended for MSM. The quadrivalent Gardasil vaccine, which targets HPV 6, 11, 16 and 18, was shown to...
Here we develop a mathematical model to explore the current vaccination strategies across Canada as well as potential alternative strategies. These strategies are defined by the number of doses given, the grade of the girls the vaccine is given to, and the coverage rate achieved. Our model will...
In Canada, two vaccines that have demonstrated high efficacy against infection with human papillomavirus (HPV) types −16 and −18 are available. The HPV-6/11/16/18 vaccine provides protection against genital warts (GW) while the HPV-16/18 vaccine may provide better protection against other...
3 Although HPV vaccination holds potential as an effective cancer control strategy, given current vaccine uptake rates and costs, secondary prevention through screening will need to continue in the coming decades4,5 and advances in improving screening remain a key priority for women’s health. For ...
Although the public vaccination program has been implemented throughout Canada, the HPV vaccine uptake rate varies across the country from as low as 50% ... N Thavarajah,E Chow,J Arocha - 《International Journal of Child & Adolescent Health》 被引量: 0发表: 2015年 HPV Vaccine Uptake in ...
Currently, at least four novel 9vHPV vaccine candidates are undergoing phase III clinical trials. When these trials are completed, their eventual market introduction is expected to alleviate the current vaccine supply pressure. Some high-income countries, including the USA, Canada, Austria, and Italy...
The human papillomavirus (HPV) vaccine is an effective means of primary prevention for HPV-associated diseases, particularly when delivered in early adolescence.1–3 HPV vaccination efforts have bee...